We’re Your Ally Against Bacterial Conjunctivitis
Good hygiene practices like frequent hand-washing can limit the spread of bacterial conjunctivitis (“pink eye”)1
. But if prevention fails...
TALK TO YOUR DOCTOR ABOUT TREATING BACTERIAL CONJUNCTIVITIS WITH VIGAMOX®
SOLUTION.
What is VIGAMOX® VIGAMOX®
Solution? Solution is an antibiotic eye
drop used to treat bacterial conjunctivitis (eye infection) caused by susceptible bacteria. VIGAMOX® by prescription only.
Solution is available
The recommended dose of VIGAMOX® Solution for patients 1 year of age and older is 1 drop in the affected eye(s) 3 times a day for 7 days.
IMPORTANT SAFETY INFORMATION Who should not use VIGAMOX® Do not use VIGAMOX®
are allergic to moxifloxacin, the active ingredient of VIGAMOX®
Solution. Solution?
Solution if you Solution, or
medications in the same antibiotic class (quinolone antibiotics), or to any component in VIGAMOX®
What should I tell my healthcare provider before using VIGAMOX®
Solution?
• Tell your healthcare provider about all your medical conditions, including:
° Any allergies, especially to quinolone antibiotics or any of the ingredients
in VIGAMOX® Solution
° If you are pregnant, planning to become pregnant, or nursing
• Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines
• Tell your healthcare provider if you wear contact lenses. Contact lenses should not be worn if you have eye redness or other signs and symptoms of bacterial conjunctivitis.
What are the most common side effects of VIGAMOX®
Solution?
The most common side effects of the eye reported with the use of VIGAMOX® Solution are eye inflammation, decreased vision, dry eye, eye discomfort, eye redness, eye pain, eye itching, and watery eyes. These side effects have occurred in approximately 1-6% of patients.
Licensed to Alcon by Bayer Intellectual Property GmbH. © 2015 Novartis | 10/15 | US-VIG-15-E-0386
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100